BACKGROUND: Although symptomatic remission is considered the optimal outcome in depression, this is not always achieved. Furthermore, symptom indicators do not fully capture patients' and clinicians' perspectives on remission. Broader indicators of (partial) remission from depression should be considered.AIMS: To investigate relevant outcomes of depression treatment in specialist care from patients' and clinicians' perspectives and to investigate whether these perspectives differ from each other.METHOD: Three focus groups with 11 patients with depression and seven semi-structured interviews with clinicians were conducted exploring their perspectives on remission. All interviews were audio-recorded and transcribed verbatim. We analysed the t...
Contains fulltext : 167842.pdf (publisher's version ) (Open Access)OBJECTIVE: Depr...
BACKGROUND.: The Leuven Affect and Pleasure Scale (LAPS) is a depression outcome measure aiming to b...
Background. A specialist depression service (SDS) offering collaborative pharmacological and cogniti...
BACKGROUND: Although symptomatic remission is considered the optimal outcome in depression, this is ...
BACKGROUND: Although symptomatic remission is considered the optimal outcome in depression, this is ...
Background: This study aimed to document the outcome dimensions that physicians see as important in ...
Background: It is unclear whether current outcome measures capture what is important to service user...
Almost one in five individuals will experience a depressive disorder during their life. Apart from t...
Background Many clinical trials have assessed treatments for depressive disorders and bipolar depres...
ABSTRACT: BACKGROUND: This study aimed to document the outcome dimensions that physicians see as im...
BACKGROUND: Depression is the leading cause of disability worldwide, and is a major contributor to t...
BACKGROUND: This study aimed to document the outcome dimensions that physicians see as important in ...
AIMS: The influence of discordance in what is important in being cured from depression on clinical o...
Background: This study aimed to document the outcome dimensions that physicians see as important in ...
Responses to evidence-based interventions for depression are divergent: Some patients benefit more t...
Contains fulltext : 167842.pdf (publisher's version ) (Open Access)OBJECTIVE: Depr...
BACKGROUND.: The Leuven Affect and Pleasure Scale (LAPS) is a depression outcome measure aiming to b...
Background. A specialist depression service (SDS) offering collaborative pharmacological and cogniti...
BACKGROUND: Although symptomatic remission is considered the optimal outcome in depression, this is ...
BACKGROUND: Although symptomatic remission is considered the optimal outcome in depression, this is ...
Background: This study aimed to document the outcome dimensions that physicians see as important in ...
Background: It is unclear whether current outcome measures capture what is important to service user...
Almost one in five individuals will experience a depressive disorder during their life. Apart from t...
Background Many clinical trials have assessed treatments for depressive disorders and bipolar depres...
ABSTRACT: BACKGROUND: This study aimed to document the outcome dimensions that physicians see as im...
BACKGROUND: Depression is the leading cause of disability worldwide, and is a major contributor to t...
BACKGROUND: This study aimed to document the outcome dimensions that physicians see as important in ...
AIMS: The influence of discordance in what is important in being cured from depression on clinical o...
Background: This study aimed to document the outcome dimensions that physicians see as important in ...
Responses to evidence-based interventions for depression are divergent: Some patients benefit more t...
Contains fulltext : 167842.pdf (publisher's version ) (Open Access)OBJECTIVE: Depr...
BACKGROUND.: The Leuven Affect and Pleasure Scale (LAPS) is a depression outcome measure aiming to b...
Background. A specialist depression service (SDS) offering collaborative pharmacological and cogniti...